Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
6.12
-0.21 (-3.24%)
Jun 13, 2025, 10:45 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Pharmaceutical
32.33M
Log In
Log In
Pharmaceutical Growth
174.98%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
32.33M
Log In
Log In
United States Growth
174.98%
Log In
Log In